
Chemicals of concern: Kratom and 7-hydroxymitragynine (7-OH)
What happens when a drug people can buy in everyday stores behaves like an opioid—yet regulators still treat it as a “gray zone”? In The Lancet Pulse episode, host Matthew Gilbert and co-host Niall Boyce are joined by Dr












